Skip to main content
    C

    Context Therapeutics Inc (CNTX)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $0.17
    -0.01 (-8.24%)

    Market Cap: $16.61M

    Last updated: Nov 17, 2026 at 11:04 AM ET

    Context Therapeutics Inc (CNTX) Earnings: Report Dates and Results

    Updated Nov 10, 2026. Results come from company earnings reports, and estimates are consensus analyst estimates.

    Context Therapeutics (CNTX) is expected to report earnings on Mar 22, 2027. In the quarter ended Sep 30, 2026, Context Therapeutics reported EPS of -$0.08, above the -$0.09 estimate. It beat the EPS estimate in 4 of the last 8 quarters.

    Earnings

    Performance (10Y)

    Beat Rate
    40%(8/20)
    Avg Surprise
    -16.21%
    Streak
    1 Q

    Upcoming Estimates

    Reports Mar 22, 2027 (est.)Period ending Dec 31, 2026
    EPS Consensus-$0.11
    Range-$0.17 - -$0.07
    11 analysts
    Revenue Consensus
    N/A
    RangeN/A
    10 analysts
    Reports May 4, 2027 (est.)Period ending Mar 31, 2027
    EPS Consensus-$0.10
    Range-$0.11 - -$0.08
    4 analysts
    EPS Revisions
    0
    1
    30d
    EPS Estimate DriftChange to current
    90d ago-$0.100.0%
    60d ago-$0.100.0%
    30d ago-$0.100.0%
    7d ago-$0.100.0%
    Current-$0.10
    Revenue Consensus
    N/A
    RangeN/A
    6 analysts

    Next Report

    CNTX has an expected report date of Mar 22, 2027.

    Earnings History

    Of the 20 quarters below that had an estimate, CNTX beat 8, missed 9 and matched 3. The widest gap in the table came in the quarter ended Sep 30, 2024, when EPS landed 144.44% below the estimate.

    Quarter endedEPSEstimateRangeSurpriseResultYoYAnalystsRevisionsReported
    Sep 30, 2026-$0.08-$0.09-$0.09 - -$0.07+11.11%BeatN/A83 up, 3 downNov 10, 2026
    Jun 30, 2026-$0.15-$0.10-$0.10 - -$0.07-50.00%MissN/A86 up, 0 downAug 5, 2026
    Mar 31, 2026-$0.09-$0.12-$0.14 - -$0.06+25.00%BeatN/A86 up, 0 downMay 6, 2026
    Dec 31, 2025-$0.14-$0.10-$0.12 - -$0.07-36.59%MissN/A91 up, 2 downMar 25, 2026
    Sep 30, 2025-$0.10-$0.09-$0.12 - -$0.03-11.11%MissN/A41 up, 2 downNov 5, 2025
    Jun 30, 2025-$0.09-$0.05-$0.08 - -$0.01-80.00%MissN/A50 up, 1 downAug 6, 2025
    Mar 31, 2025-$0.05-$0.06-$0.10 - -$0.04+16.67%BeatN/A31 up, 1 downMay 7, 2025
    Dec 31, 2024-$0.03-$0.06-$0.22 - -$0.04+47.09%BeatN/A51 up, 0 downMar 20, 2025
    Sep 30, 2024-$0.22-$0.09-$0.16 - -$0.05-144.44%MissN/A20 up, 0 downNov 6, 2024
    Jun 30, 2024-$0.04-$0.07-$0.08 - -$0.07+42.86%BeatN/A20 up, 0 downAug 7, 2024
    Mar 31, 2024-$0.23-$0.44-$0.44 - -$0.44+47.73%BeatN/A11 up, 0 downMay 8, 2024
    Dec 31, 2023-$0.42-$0.35-$0.38 - -$0.32-20.00%MissN/A20 up, 0 downMar 21, 2024
    Sep 30, 2023-$0.37-$0.31N/A-19.35%MissN/AN/AN/ANov 9, 2023
    Jun 30, 2023-$0.31-$0.20N/A-55.00%MissN/AN/AN/AAug 9, 2023
    Mar 31, 2023-$0.40-$0.19N/A-110.53%MissN/AN/AN/AMay 10, 2023
    Dec 31, 2022-$0.22-$0.22N/A0.00%In lineN/AN/AN/AMar 22, 2023
    Sep 30, 2022-$0.24-$0.25N/A+4.00%BeatN/AN/AN/ANov 9, 2022
    Jun 30, 2022-$0.25-$0.25N/A0.00%In line-125.8%N/AN/AAug 11, 2022
    Mar 31, 2022-$0.22-$0.24N/A+8.33%BeatN/AN/AN/AMay 11, 2022
    Dec 31, 2021-$0.58-$0.58N/A0.00%In lineN/AN/AN/AMar 24, 2022
    Sep 30, 2021-$0.46N/AN/AN/AN/AN/AN/AN/ADec 2, 2021
    Jun 30, 2021$0.97N/AN/AN/AN/AN/AN/AN/AJul 2, 2021
    Sep 30, 2018-$0.88N/AN/AN/AN/AN/AN/AN/ANov 9, 2018
    Last 23 quarters

    Annual EPS

    EPS for the fiscal year ended Dec 31, 2025 was -$0.38, after -$0.52 the year before. It was -$0.95 for the year ended Dec 31, 2021, the oldest of the 5 fiscal years shown.

    Fiscal year endedEPSChange
    Dec 31, 2025-$0.38N/A
    Dec 31, 2024-$0.52N/A
    Dec 31, 2023-$1.50N/A
    Dec 31, 2022-$0.93N/A
    Dec 31, 2021-$0.95N/A

    Frequently Asked Questions About CNTX

    When is Context Therapeutics's next earnings date?

    Context Therapeutics's next earnings report is expected for Mar 22, 2027.

    Did CNTX beat earnings estimates last quarter?

    Yes. Context Therapeutics reported EPS of -$0.08 for the quarter ended Sep 30, 2026, above the -$0.09 estimate, a 11.11% surprise.

    What EPS do analysts expect from CNTX next quarter?

    The consensus EPS estimate for Context Therapeutics for the quarter ending Dec 31, 2026 is -$0.11 from 11 analysts, with estimates from -$0.17 to -$0.07.

    How often does CNTX beat earnings estimates?

    Context Therapeutics beat the EPS estimate in 4 of the last 8 quarters, with an average surprise of -9.73%.